NYSE:QGEN - Qiagen Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $54.13
  • Forecasted Upside: 12.03 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$48.32
▲ +0.47 (0.98%)

This chart shows the closing price for QGEN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Qiagen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for QGEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for QGEN

Analyst Price Target is $54.13
▲ +12.03% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is $54.13, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 12.03% upside from the last price of $48.32.

This chart shows the closing price for QGEN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 contributing investment analysts is to hold stock in Qiagen. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 9 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/17/2022DZ BankUpgradeHold ➝ BuyLow
12/14/2021Wells Fargo & CompanyBoost Price TargetEqual Weight$58.00 ➝ $60.00High
11/26/2021Kepler Capital MarketsDowngradeHold$49.00High
10/21/2021Norddeutsche LandesbankReiterated RatingHoldLow
10/14/2021Redburn PartnersInitiated CoverageBuyLow
7/14/2021CheuvreuxDowngradeBuy ➝ Hold$49.53Medium
7/14/2021Kepler Capital MarketsDowngradeBuy ➝ Hold$49.53Medium
7/14/2021CitigroupLower Price TargetBuy$65.00 ➝ $58.00Medium
7/9/2021Kepler Capital MarketsUpgradeBuy$51.00High
6/25/2021DZ BankReiterated RatingNeutralLow
6/17/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
6/11/2021Berenberg BankReiterated RatingBuyLow
6/8/2021The Goldman Sachs GroupReiterated RatingBuyLow
6/3/2021The Goldman Sachs GroupInitiated CoverageNeutral$52.00Low
5/4/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
4/22/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
4/7/2021DZ BankReiterated RatingNeutralMedium
4/2/2021Kepler Capital MarketsReiterated RatingBuyN/A
4/1/2021DZ BankReiterated RatingNeutralLow
2/19/2021Berenberg BankReiterated RatingBuyMedium
2/17/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
2/10/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
1/6/2021Norddeutsche LandesbankReiterated RatingHoldN/A
1/6/2021Nord/LBReiterated RatingNeutralN/A
12/14/2020DZ BankReiterated RatingSellLow
12/10/2020Exane BNP ParibasReiterated RatingOutperformHigh
12/9/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
12/9/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
11/26/2020Kepler Capital MarketsUpgradeBuyLow
11/11/2020DZ BankReiterated RatingSellMedium
11/4/2020Berenberg BankReiterated RatingBuyLow
10/28/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
10/6/2020Bank of AmericaUpgradeNeutral ➝ Buy$59.00Medium
9/28/2020Kepler Capital MarketsUpgradeHold ➝ Buy$59.32Medium
9/15/2020DZ BankReiterated RatingNeutralLow
8/30/2020Kepler Capital MarketsUpgradeHoldLow
8/26/2020CommerzbankUpgradeHold ➝ Buy$66.00Low
8/24/2020CitigroupUpgradeNeutral ➝ Buy$48.00 ➝ $62.00Medium
8/20/2020JPMorgan Chase & Co.Reiterated RatingOverweight$60.00Low
8/17/2020Wolfe ResearchInitiated CoverageMarket Perform$59.00Low
8/17/2020Berenberg BankUpgradeHold ➝ BuyHigh
8/14/2020Exane BNP ParibasUpgradeNeutral ➝ OutperformHigh
8/14/2020BNP ParibasUpgradeNeutral ➝ OutperformMedium
8/14/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$32.00 ➝ $60.00High
7/20/2020DZ BankReiterated RatingNeutralLow
7/14/2020DZ BankReiterated RatingNeutralMedium
6/23/2020Warburg ResearchReiterated RatingHold ➝ NeutralLow
5/29/2020DZ BankReiterated RatingNeutralLow
5/6/2020Warburg ResearchReiterated RatingHoldLow
4/2/2020Stifel NicolausBoost Price TargetHold$33.00 ➝ $40.00Low
3/25/2020Kepler Capital MarketsReiterated RatingHoldLow
3/6/2020CfraBoost Price TargetHold$38.00 ➝ $42.00Low
3/4/2020Berenberg BankDowngradeBuy ➝ HoldMedium
3/3/2020DZ BankReiterated RatingNeutralLow
2/11/2020DZ BankReiterated RatingNeutralLow
2/6/2020CfraLower Price TargetHold$40.00 ➝ $38.00Medium
2/6/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
2/5/2020Piper SandlerBoost Price TargetNeutral$29.00 ➝ $36.00Medium
2/5/2020BarclaysReiterated RatingNeutralHigh
2/5/2020CommerzbankReiterated RatingNeutralMedium
1/10/2020UBS GroupLower Price TargetNeutral$39.00 ➝ $36.00Medium
1/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$36.00Medium
1/6/2020CitigroupInitiated CoverageNeutral$35.00Low
1/6/2020JPMorgan Chase & Co.Reiterated RatingBuyLow
1/6/2020CommerzbankDowngradeBuy ➝ HoldLow
1/2/2020DZ BankReiterated RatingNeutralLow
12/27/2019DZ BankReiterated RatingNeutralLow
12/26/2019UBS GroupReiterated RatingHold$39.00Medium
12/26/2019Bank of AmericaReiterated RatingUnderperform$28.00High
11/27/2019CommerzbankUpgradeHold ➝ BuyLow
11/22/2019DZ BankReiterated RatingBuyLow
11/18/2019CommerzbankUpgradeHold ➝ Buy$48.00Medium
11/14/2019Stifel NicolausInitiated CoverageHold$33.00High
11/14/2019DZ BankReiterated RatingBuyLow
11/14/2019Evercore ISIUpgradeIn-Line ➝ OutperformLow
11/14/2019Kepler Capital MarketsUpgradeReduce ➝ HoldHigh
11/14/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Overweight$25.00 ➝ $40.00High
10/17/2019Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
10/9/2019UBS GroupReiterated RatingNeutralHigh
10/9/2019Kepler Capital MarketsDowngradeHold ➝ ReduceHigh
10/8/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldHigh
10/8/2019Bank of AmericaLower Price TargetNeutral$40.00 ➝ $33.00High
10/8/2019BarclaysDowngradeOverweight ➝ Equal Weight$32.00High
10/8/2019Piper Jaffray CompaniesLower Price TargetNeutral$36.00 ➝ $31.00High
10/8/2019JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$38.00 ➝ $25.00High
10/1/2019Berenberg BankReiterated RatingBuyHigh
8/1/2019The Goldman Sachs GroupReiterated RatingBuyLow
7/26/2019Berenberg BankReiterated RatingBuy$40.00Low
7/26/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
7/24/2019DZ BankReiterated RatingNeutralLow
7/12/2019Exane BNP ParibasUpgradeNeutral ➝ OutperformLow
7/12/2019BNP ParibasUpgradeNeutral ➝ OutperformLow
6/21/2019BarclaysBoost Price TargetOverweight$43.00 ➝ $45.00Low
6/21/2019The Goldman Sachs GroupReiterated RatingBuyLow
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/8/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
5/7/2019The Goldman Sachs GroupReiterated RatingBuyHigh
4/12/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
3/15/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$42.00Low
1/29/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
1/21/2019Jefferies Financial GroupReiterated RatingNeutralLow
1/14/2019Jefferies Financial GroupReiterated RatingNeutralLow
10/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$39.00 ➝ $41.00Low
10/30/2018BarclaysReiterated RatingBuyLow
10/30/2018CommerzbankReiterated RatingBuyMedium
10/30/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyHigh
10/22/2018CommerzbankReiterated RatingBuyLow
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $39.00Low
10/5/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$43.00 ➝ $44.00Medium
10/5/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy ➝ Buy$43.00 ➝ $44.00Low
9/17/2018CommerzbankReiterated RatingBuyMedium
9/6/2018BarclaysReiterated RatingBuy$43.00Low
8/29/2018CommerzbankReiterated RatingBuyLow
8/7/2018CommerzbankReiterated RatingBuyLow
8/3/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
8/2/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$38.00 ➝ $39.00Low
8/2/2018CitigroupBoost Price TargetNeutral ➝ Neutral$35.00 ➝ $38.00Low
8/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$37.00 ➝ $38.00Low
7/25/2018CommerzbankReiterated RatingBuyMedium
6/6/2018Jefferies Financial GroupReiterated RatingNeutralLow
6/5/2018DZ BankReiterated RatingNeutralLow
5/16/2018The Goldman Sachs GroupReiterated RatingBuyLow
5/9/2018CommerzbankReiterated RatingBuyLow
5/4/2018CitigroupBoost Price TargetNeutral ➝ Neutral$31.00 ➝ $35.00Low
5/3/2018JPMorgan Chase & Co.Reiterated RatingNeutralLow
5/3/2018CommerzbankReiterated RatingBuyLow
4/24/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Buy$38.00 ➝ $40.00Low
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$39.00 ➝ $37.00Medium
4/5/2018DZ BankReiterated RatingNeutralMedium
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $39.00Low
2/1/2018CommerzbankReiterated RatingBuyHigh
1/29/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$39.00Low
1/22/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
1/19/2018CommerzbankReiterated RatingBuyMedium
1/10/2018CommerzbankReiterated RatingBuyLow
1/3/2018Evercore ISIInitiated CoverageOutperform$35.00Medium
12/21/2017CowenReiterated RatingHold$34.00Low
12/19/2017DZ BankReiterated RatingNeutralLow
12/12/2017CommerzbankReiterated RatingBuyLow
12/1/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
11/8/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
11/7/2017JPMorgan Chase & Co.Reiterated RatingNeutralN/A
11/7/2017CommerzbankReiterated RatingBuyN/A
11/3/2017CowenReiterated RatingHold$33.00N/A
9/28/2017CowenReiterated RatingHold$33.00Low
8/28/2017DZ BankReiterated RatingNeutralLow
8/17/2017CommerzbankReiterated RatingBuyLow
8/14/2017CowenReiterated RatingHold$33.00Low
8/1/2017Independent ResearchUpgradeSell ➝ HoldLow
7/31/2017Jefferies Financial GroupReiterated RatingHold$25.00 ➝ $28.00Low
7/31/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
7/28/2017CommerzbankReiterated RatingBuyHigh
7/24/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
7/21/2017Bank of AmericaReiterated RatingNeutral$33.00 ➝ $36.00Low
7/17/2017BarclaysReiterated RatingOverweight$33.00 ➝ $37.00Low
7/13/2017Wells Fargo & CompanyReiterated RatingMarket Perform$28.00 ➝ $31.00Low
7/10/2017Morgan StanleyReiterated RatingOverweight$36.00 ➝ $37.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.10 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/7/2021
  • 2 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 4 very negative mentions
1/6/2022
  • 4 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
2/5/2022
  • 5 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/6/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/6/2022
  • 1 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/5/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
7/5/2022

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Qiagen logo
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Read More

Today's Range

Now: $48.32
Low: $47.35
High: $48.35

50 Day Range

MA: $45.61
Low: $42.98
High: $48.32

52 Week Range

Now: $48.32
Low: $41.32
High: $58.00

Volume

1,312,438 shs

Average Volume

815,089 shs

Market Capitalization

$10.97 billion

P/E Ratio

18.88

Dividend Yield

N/A

Beta

0.23

Frequently Asked Questions

What sell-side analysts currently cover shares of Qiagen?

The following Wall Street analysts have issued reports on Qiagen in the last year: Cheuvreux, Citigroup Inc., DZ Bank AG, Kepler Capital Markets, Norddeutsche Landesbank, Redburn Partners, and Wells Fargo & Company.
View the latest analyst ratings for QGEN.

What is the current price target for Qiagen?

0 Wall Street analysts have set twelve-month price targets for Qiagen in the last year. Their average twelve-month price target is $54.13, suggesting a possible upside of 12.0%.
View the latest price targets for QGEN.

What is the current consensus analyst rating for Qiagen?

Qiagen currently has 4 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in QGEN, but not buy more shares or sell existing shares.
View the latest ratings for QGEN.

How do I contact Qiagen's investor relations team?

Qiagen's physical mailing address is HULSTERWEG 82, VENLO P7, 5912. The company's listed phone number is (177) 355-6600 and its investor relations email address is [email protected] The official website for Qiagen is www.qiagen.com. Learn More about contacing Qiagen investor relations.